✦ LIBER ✦

763 All-Oral Therapy With Daclatasvir in Combination With Asunaprevir and Bms-791325 for Treatment-Naive Patients With Chronic HCV Genotype 4 Infection

✍ Scribed by Hassanein, Tarek; Everson, Gregory T.; Sims, Karen; Bennett, Michael T.; Gitlin, Norman; Lawitz, Eric; Nguyen, Tuan T.; Webster, Lynn R.; Younossi, Zobair M.; Schwartz, Howard I.; Thuluvath, Paul J.; Zhou, Helen; Rege, Bhaskar; McPhee, Fiona; Wind-Rotolo, Megan; Chung, Ellen; Griffies, Amber M.; Grasela, Dennis M.; Gardiner, David F.

Book ID: 122316534
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 166 KB
Volume: 146
Category: Article
ISSN: 0016-5085
DOI: 10.1016/S0016-5085(14)63364-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P1163 ALL-ORAL THERAPY WITH DACLATASVIR

P1163 ALL-ORAL THERAPY WITH DACLATASVIR IN COMBINATION WITH ASUNAPREVIR AND BMS-791325 FOR TREATMENT-NAIVE PATIENTS WITH CHRONIC HCV GENOTYPE 4 INFECTION

✍ Hassanein, T.; Sims, K.; Bennett, M.; Gitlin, N.; Lawitz, E.; Nguyen, T.; Webste 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 60 KB

Efficacy of an Interferon- and Ribavirin

Efficacy of an Interferon- and Ribavirin-Free Regimen of Daclatasvir, Asunaprevir, and BMS-791325 in Treatment-Naive Patients With HCV Genotype 1 Infection

✍ Everson, Gregory T.; Sims, Karen D.; Rodriguez-Torres, Maribel; Hézode, Christop 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 608 KB

Dual oral therapy with daclatasvir and a

Dual oral therapy with daclatasvir and asunaprevir for patients with HCV genotype 1b infection and limited treatment options

✍ Suzuki, Yoshiyuki; Ikeda, Kenji; Suzuki, Fumitaka; Toyota, Joji; Karino, Yoshiya 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 941 KB

O166 ALL-ORAL DUAL THERAPY WITH DACLATAS

O166 ALL-ORAL DUAL THERAPY WITH DACLATASVIR AND ASUNAPREVIR IN PATIENTS WITH HCV GENOTYPE 1B INFECTION: PHASE 3 STUDY RESULTS

✍ Manns, M.; Pol, S.; Jacobson, I.; Marcellin, P.; Gordon, S.; Peng, C.-Y.; Chang, 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 120 KB

All-oral combination of ledipasvir, vedr

All-oral combination of ledipasvir, vedroprevir, tegobuvir, and ribavirin in treatment-naïve patients with genotype 1 HCV infection

✍ Wyles, David L.; Rodriguez-Torres, Maribel; Lawitz, Eric; Shiffman, Mitchell L.; 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 593 KB

1096 ASUNAPREVIR (ASV; BMS-650032), AN N

1096 ASUNAPREVIR (ASV; BMS-650032), AN NS3 PROTEASE INHIBITOR, IN COMBINATION WITH PEGINTERFERON AND RIBAVIRIN IN TREATMENT-NAIVE PATIENTS WITH GENOTYPE 1 CHRONIC HEPATITIS C INFECTION

✍ Bronowicki, J.-P.; Pol, S.; Thuluvath, P.; Larrey, D.; Martorell, C.T.; Rustgi, 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 72 KB